Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Phase 1 Trial
Biotech
From
Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
Tickers
ABBV
ALLO
ARGX
AZN
Tags
General
CLLS
BLUE
From
Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
December 10, 2021
Tickers
BMY
INFI
RHHBF
RHHBY
Tags
RHHBF
RHHVF
breast cancer
From
Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
December 10, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
General
From
Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
Tickers
BRK-A
BRK-B
HALO
LGVN
Tags
TEVA
BRK/A
MRNA
From
InvestorPlace
Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19
December 07, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
FDA
Benzinga
Market News
From
Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
December 06, 2021
Tickers
IMCR
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
Solid Tumor
From
Benzinga
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
December 04, 2021
Tickers
ADAP
AGEN
ALPMY
GSK
Tags
XBI
OCGN
AGEN
From
Motley Fool
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
December 03, 2021
Tickers
ABT
BDX
CI
CVS
Tags
News
ABT
Regulations
From
Benzinga
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
December 02, 2021
Tickers
ALPMF
ALPMY
NVS
RHHBF
Tags
Health Care
Contracts
Biotech
From
Benzinga
52 Biggest Movers From Yesterday
December 01, 2021
Tickers
ACET
AERC
AIH
ANNX
Tags
CTIC
IBRX
CLNN
From
Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
November 30, 2021
Tickers
ADAG
ADGI
AERC
ARRY
Tags
MOLN
IMGN
SNEX
From
Benzinga
ImmunoGen Shares Rally After Ovarian Cancer Trial Meets Primary Endpoint Goal
November 30, 2021
Tickers
IMGN
RHHBY
Tags
Ovarian Cancer
IMGN
RHHBY
From
Benzinga
As FINRA's OTC Bulletin Board Closes Down, OTC Markets Group Becomes the Main Gateway Into the Regulated Over-the-Counter Market
November 30, 2021
Tickers
ADDYY
DANOY
OTCM
RHHBY
Tags
Benzinga
Market News
Markets
From
Benzinga
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
November 28, 2021
Tickers
BIIB
RHHBY
Tags
BIIB
Recent Press Releases
RHHBY
From
Motley Fool
Detecting Early Cancer Screening Stocks At An Early Stage Is Critical
November 22, 2021
Tickers
BMKDF
GH
MRNA
PFE
Tags
Benzinga
PFE
contributors
From
Benzinga
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
Tickers
AMGN
AZN
BIIB
BMY
Tags
NVS
SNY
RHHBY
From
Motley Fool
Why Regeneron's Results for Its COVID Antibody Therapy Won't Boost Sales Much
November 20, 2021
Tickers
MRK
PFE
REGN
RHHBY
Tags
RHHBY
Recent Press Releases
REGN
From
Motley Fool
Ocugen Stock: Bull vs. Bear
November 20, 2021
Tickers
BIIB
EDIT
JNJ
MRNA
Tags
OCGN
PFE
NVAX
From
Motley Fool
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
November 19, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
Briefs
From
Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
Movers
BMRN
News
From
Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes
November 18, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Phase 1 Trial
gene therapy
From
Benzinga
3 Biotech Stocks That Have More Than Tripled so far This Year
November 18, 2021
Tickers
BIIB
BNTX
LLY
OCGN
Tags
SAVA
Recent Press Releases
BIIB
From
Motley Fool
Why Atea Pharmaceuticals Stock Is Sinking Today
November 17, 2021
Tickers
AVIR
MRK
PFE
RHHBY
Tags
Recent Press Releases
RHHBY
Market News
From
Motley Fool
Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill
November 17, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
Biotech
Small Cap
Contracts
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 17, 2021
Tickers
APWC
AVIR
CEI
CNSP
Tags
Market News
TLMD
CEI
From
InvestorPlace
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
November 12, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Biotech
Health Care
REGN
From
Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Tickers
ADPT
AFIB
ANVS
ATHX
Tags
AFIB
MDNA
Small Cap
From
Benzinga
EU Regulator Backs Regeneron-Roche's COVID-19 Drug
November 11, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Market News
FDA
Benzinga
From
Benzinga
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
November 10, 2021
Tickers
BIIB
LLY
RHHBF
RHHBY
Tags
Briefs
News
General
From
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.